27
2013-10-27

Naprapath Titti Lilje has conducted the first health economic study on the treatment and cost-effectiveness of naprapathy for so-called non-priority orthopedic outpatient cases.

The study was recently published in the Clinical Journal of Pain. A randomized clinical trial involving 78 patients demonstrated that naprapathic treatment was more effective than conventional orthopedic care for various common musculoskeletal conditions, particularly those affecting the shoulder/arm and knee/foot. A health economic evaluation also showed that naprapathy was more cost-effective. The study was conducted in collaboration with the Swedish Institute for Health Economics and Karolinska Institutet.
Read the full article “Common musculoskeletal conditions should be treated with naprapathy” in Läkartidningen.